Keystone Financial Planning, Inc. Merck & Co., Inc. Transaction History

Keystone Financial Planning, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$83.49 - $94.64 $7.72 Million - $8.75 Million	-92,448 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$73.51 - $82.4 $36,902 - $41,364	-502 Reduced 0.54%	92,448 $7.59 Million
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $214,527 - $268,722	2,968 Added 3.3%	92,950 $7.12 Million
Q3 2021 Oct 15, 2021	BUY	$71.68 - $78.83 $1.02 Million - $1.12 Million	14,247 Added 18.81%	89,982 $6.76 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $5.32 Million - $5.89 Million	75,735 New	75,735 $5.89 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Keystone Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Keystone Financial Planning, Inc. with notifications on news.